Chimeric Therapeutics
(ASX) CHM
Chimeric Therapeutics Financials at a Glance
Market Cap
$8.22M
Revenue (TTM)
$7.36M
Net Income (TTM)
$32.83M
EPS (TTM)
$-0.01
P/E Ratio
-0.28
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$0.00
Volume
276,000
Open
$0.00
Price
$0.00
Volume
276,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
0.30 (Low)
Price
$0.00
Volume
276,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
CHM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chimeric Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Rebecca McQualter, PhD
Website
www.chimerictherapeutics.comHeadquarters
Carlton, VIC 3053, AU
CHM Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
-5%
Net Income Margin
-4%
Return on Equity
-1291%
Return on Capital
11%
Return on Assets
-3%
Earnings Yield
-3.57%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.22M
Shares Outstanding
4.11B
Volume
276.00K
Short Interest
0.00%
Avg. Volume
4.08M
Financials (TTM)
Gross Profit
$3.12M
Operating Income
$15.11M
EBITDA
$9.08M
Operating Cash Flow
$7.28M
Capital Expenditure
$0.00
Free Cash Flow
$7.28M
Cash & ST Invst.
$5.76M
Total Debt
$0.00
Chimeric Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$486.78K
-109.7%
Gross Margin
0.00%
N/A
Market Cap
$8.22M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$11.22M
-558.9%
EBITDA
$3.40M
-28.3%
Quarterly Fundamentals
Net Cash
$2.50M
-29.0%
Accounts Receivable
$2.53M
-75.9%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-2.53%
N/A
Return on Invested Capital
11.24%
N/A
Free Cash Flow
$3.84M
+17.5%
Operating Cash Flow
$3.84M
+17.5%